Gainers on news: Prana Biotechnology (PRAN +14.75%) Announced that PBT2 reduces cognitive impairment caused by tau protein accumulation Coronado Biosciences (CNDO +3.29%) Positively mentioned in blog article. Decliners on earnings: Dynavax Technologies (DVAX -3.54%) Reported net loss of -$0.11 vs -$0.08 estimate, revs fell 85% yoy to $1.806 mln vs $6.91 mln estimate Arena Pharmaceuticals (ARNA -3.00%) Missed quarterly EPS by $0.05 (-$0.10 vs -$0.05 estimate), revs fell 9.5% yoy to $1.9 mln vs $49.72 mln estimate Myriad Genetics (MYGN -2.04%) Sees FY13 EPS at higher end of prior range of $1.55-1.58 vs $1.58 estimate, sees FY13 revs at higher end of prior range of $575-585 mln vs $583.30 mln estimate PDL BioPharma (PDLI -0.22%) Beat quarterly EPS by $0.03 ($0.34 vs $0.31 estimate), revs rose 18.3% yoy to $86.1 mln vs the $86 mln preannouncement TSON -0.90%, PDLI -0.14%






